Orphalan
146 employees on LinkedIn · 1 known investors
Orphalan is a global pharmaceutical company that identifies, develops, and commercializes orphan drugs for patients with rare diseases, including treatments for Wilson disease. It also serves rare and serious pediatric conditions in neurology and oncology following its acquisition of Orphelia Pharma.
Investors · 1
In the news
Frequently asked questions
- What does Orphalan do?
- Orphalan is a global pharmaceutical company that identifies, develops, and commercializes orphan drugs for patients with rare diseases, including treatments for Wilson disease. It also serves rare and serious pediatric conditions in neurology and oncology following its acquisition of Orphelia Pharma.
- Who are Orphalan's investors?
- Orphalan's investors include Advent Life Sciences.